The Clorox Company demonstrated resilience in Q2 FY2026, reaffirming guidance amidst a challenging macroeconomic landscape and ongoing ERP implementation, while signaling optimism for the future driven by strategic initiatives.

• Results were largely in line with expectations, indicating stability despite external pressures and the temporary effects of ERP rollouts.
• The planned acquisition of Gojo Industries is aimed at strengthening Clorox's leadership in health and hygiene and unlocking long-term growth opportunities.
• Sequential improvement in performance observed, with stronger share gains noted in late January, fueled by effective investments and innovation plans.
• Competitive environment has stabilized to pre-COVID levels, with Clorox prepared to address intense competition in key categories.
• Guidance for category growth remains projected between 0% to 1% for the fiscal year, reflecting steady consumer behavior in alignment with broader market trends.